Clients

Neovasc Inc.

Company Snapshot: Neovasc Inc.

NVCN
Last Change Volume High Low

Company Overview

Neovasc Inc., a specialty medical device company, develops, manufactures, and markets medical devices for cardiovascular marketplace in Europe, the United States, and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.

Client News

  1. Aug 11 2022 Neovasc Announces Second Quarter Financial Results and Provides Corporate Update
  2. Aug 11 2022 Neovasc Announces Second Quarter Financial Results and Provides Corporate Update
  3. Jul 28 2022 Neovasc to Report Second Quarter Financial Results on August 11, 2022
  4. Jul 26 2022 Neovasc Announces FDA Approval of Planned COSIRA II Sub-studies and Single Arm Registry to Allow Inclusion of Additional Specified Patient Populations